Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.46 |
| ▸ | CPS1 | P31327 | 9/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3776840 | 1.00 | ABCG2 (0.46) | ABCG2CPS1NFE2L2RELAMAOB | |
| SCHEMBL3660866 | 0.88 | CPS1 (0.39) | ABCG2CPS1NFE2L2RELAMAOB | |
| SCHEMBL3771354 | 0.88 | CPS1 (0.39) | ABCG2CPS1NFE2L2RELAMAOB | |
| SCHEMBL3662395 | 0.83 | NFE2L2 (0.38) | NFE2L2MAPT | |
| SCHEMBL3769989 | 0.83 | ALDH1A1 (0.37) | ABCG2NFE2L2ALDH1A1 | |
| SCHEMBL3776287 | 0.83 | NFE2L2 (0.38) | NFE2L2MAPT | |
| SCHEMBL1023309 | 0.83 | ALDH1A1 (0.37) | ABCG2NFE2L2ALDH1A1 | |
| SCHEMBL3662315 | 0.80 | ABCG2 (0.44) | ABCG2NFE2L2RELAMAPT | |
| SCHEMBL3662316 | 0.80 | ABCG2 (0.44) | ABCG2NFE2L2RELAMAPT | |
| SCHEMBL3769358 | 0.80 | TRPA1 (0.39) | ABCG2RELAKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100317515-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | BASF SE (DE) | 2010-12-16 | — | — | US | disclosed |
| EP-2234488-A2 | AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009077443-A2 | AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME | BASF SE (DE) | 2009-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317515-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | XDH, NOX5, TET1 | ABCG2 2920/4885CPS1 221/4885NFE2L2 825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.